Record Details

Friuli Venezia Giulia

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Friuli Venezia Giulia
 
Creator Cavallo, Maria Caterina
Cipriani, Filippo
Gerzeli, Simone
Demarteau, Nadia
Marocco, Alessia
Bamfi, Francesco
 
Subject Pharmacoeconomics; Health economics
Friuli Venezia Giulia; HPV vaccination; Economic & clinical impact
 
Description In Friuli Venezia Giulia region 75,1% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 15 cases of cervicocarcinoma and 6 related deaths and thus results to be cost-effective (27.766 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 14 cancer cases and 6 deaths could be prevented, with a very similar cost-effectiveness ratio. In Friuli Venezia Giulia region, the net cost for woman vaccinated is 167 € for the single cohort and 169 € for the multiple cohort.
 
Publisher SEEd Medical Publishers
 
Date 2008-09-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/1005
10.7175/fe.v9i1S.1005
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1S (2008); 35-37
2240-256X
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/1005/1223
 
Rights Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0